Sterile Compounding Procedures
HayatiPharmacy Sterile and Nonsterile Compounding
# Sterile Compounding Procedures
Question 1 (5 points)
Which chapters of the USP are applicable to nutritional supplements?
Question 1 options:
|
|
||
|
|
||
|
|
||
|
|
When administering a TPN, the bag should be discarded how often?
Question 2 options:
|
|
||
|
|
||
|
|
||
|
|
Question 3 (5 points)
In which locations should sterile supplies be removed from their outer wrappings?
Question 3 options:
|
|
||
|
|
||
|
|
||
|
|
Which of the following is responsible for creating the compounding record (CR) for each CSP?
Question 4 options:
|
|
||
|
|
||
|
|
||
|
|
Question 5 (5 points)
Which of the following microbial growth mediums would be used to sample for fungi bacterial growth in the sterile environment?
Question 5 options:
|
|
||
|
|
||
|
|
||
|
|
When a nonsterile product is used in the preparation of a Category 2 CSP
Question 6 options:
|
|
||
|
|
||
|
|
||
|
|
Question 7 (5 points)
500 mL of 20% Liposyn provides
Question 7 options:
|
|
||
|
|
||
|
|
||
|
|
This critical site must always be exposed to first air and swabbed with a sterile IPA pad.
Question 8 options:
|
|
||
|
|
||
|
|
||
|
|
Question 9 (5 points)
A ___ should be placed on a CSP to ensure it hasn't been compromised during transport.
Question 9 options:
|
|
||
|
|
||
|
|
||
|
|
The temperature of the refrigerator used to store CSP must be checked ___ to ensure the stability of the CSP.
Question 10 options:
|
|
||
|
|
||
|
|
||
|
|
Question 11 (5 points)
Growth media used for surface sampling must be inverted and placed in an incubator for ___ at 20° to 25° C followed by an additional 2 to 3 days at 30° to 35° C.
Question 11 options:
|
|
||
|
|
||
|
|
||
|
|
Calculations a technician performs for the CSP should be located on the
Question 12 options:
|
|
||
|
|
||
|
|
||
|
|
Question 13 (5 points)
In an ISO Class 8 environment, the air contains no more than ___ particles of 0.5 microns per cubic meter.
Question 13 options:
|
|
||
|
|
||
|
|
||
|
|
Question 14 (5 points)
In which environment should documentation of CSPs be performed?
Question 14 options:
|
|
||
|
|
||
|
|
||
|
|
Question 15 (5 points)
Surface sampling of the interior of a PEC in a SCA is required ___
Question 15 options:
|
|
||
|
|
||
|
|
||
|
|
Certification of an ISO Class 5, 7, or 8 compounding environment includes
Question 16 options:
|
|
||
|
|
||
|
|
||
|
|
Question 17 (5 points)
Before withdrawing fluid from a vial using a standard non-vented needle, which of the following should be done to prevent creating a vacuum in the vial?
Question 17 options:
|
|
||
|
|
||
|
|
||
|
|
A technician is staging the final IV preparation. This is done for the pharmacist to _____ the admixture.
Question 18 options:
|
|
||
|
|
||
|
|
||
|
|
Question 19 (5 points)
___ is an example of a fat source used in parenteral solutions.
Question 19 options:
|
|
||
|
|
||
|
|
||
|
|
Visual inspection of the CSP should be performed ___ the final pharmacist check.
Question 20 options:
|
|
||
|
|
||
|
|
||
|
|